Westwood Wealth Management Biogen Inc. Transaction History

Westwood Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $11,129 - $13,397	-50 Reduced 4.26%	1,125 $291,000
Q1 2023 Apr 25, 2023	SELL	$256.56 - $292.34 $34,635 - $39,465	-135 Reduced 10.31%	1,175 $326,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $34,079 - $41,407	135 Added 11.49%	1,310 $362,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $26,283 - $36,242	-135 Reduced 10.31%	1,175 $314,000
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $286,936 - $341,220	-1,530 Reduced 53.87%	1,310 $267,000
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $271,278 - $341,796	-1,400 Reduced 33.02%	2,840 $598,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $949,420 - $1.22 Million	4,240 New	4,240 $1.02 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Westwood Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Westwood Wealth Management with notifications on news.